GlassScriptPhysician profile
Nora L Chan
NPI 1073774725
$37,306.76
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $11K · 2023: $1,586 · 2024: $25.30 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $432 · Education: $33.21 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $432.38 |
| Education | $33.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $14,398.34 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $10,304.07 | 2019-2025 | Crexont |
| Kyowa Kirin, INC. | $5,350.00 | 2020 | |
| Abbvie INC. | $4,221.86 | 2019-2025 | Duopa |
| Acadia Pharmaceuticals INC | $2,404.09 | 2020-2025 | Nuplazid |
| Medtronic USA, INC. | $204.93 | 2019 | |
| Abbott Laboratories | $143.15 | 2019-2024 | Navitor |
| Merz Pharmaceuticals, LLC | $60.40 | 2025 | Xeomin, Inbrija, Ampyra |
| Allergan, INC. | $35.00 | 2019 | |
| Axsome Therapeutics, INC. | $33.15 | 2025 | Symbravo |
| Vanda Pharmaceuticals INC. | $32.09 | 2025 | Ponvory |
| Sk Life Science, INC. | $27.98 | 2025 | |
| Medtronic, INC. | $25.84 | 2025 | Percept PC Brainsense |
| Boston Scientific Corporation | $24.46 | 2025 | General - Pain Management |
| Argenx US, INC. | $21.31 | 2025 | Vyvgart |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $20.09 | 2025 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.